{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-076333","form_type":"8-K","ticker":"TCRT","cik":"0001107421","company_name":"Alaunos Therapeutics, Inc.","filed_at":"2024-06-21T23:59:59+00:00","discovered_at":"2026-05-14T18:03:17.307990+00:00","generated_at":"2026-06-01T02:41:57.589729+00:00","sec_items":["4.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Alaunos Therapeutics dismisses RSM, engages Cherry Bekaert as auditor","bullets":["Dismissed RSM US LLP as independent auditor on June 19, 2024; no disagreements reported.","Appointed Cherry Bekaert LLP as successor independent auditor effective June 19, 2024.","RSM's reports for FY 2023 and 2022 included going concern qualification.","Change approved by Audit Committee; no reportable events in prior periods."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-076333","json":"https://secwatch.observer/filing/0000950170-24-076333.json","markdown":"https://secwatch.observer/filing/0000950170-24-076333.md","text":"https://secwatch.observer/filing/0000950170-24-076333.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1107421/000095017024076333/0000950170-24-076333-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1107421/000095017024076333/tcrt-20240619.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T02:41:57.589729+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}